SCHEMBL8407630

SCHEMBL8407630

Cc1ccc(-c2nc3ccccc3nc2-c2ccccc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 1.00
KDM4E B2RXH2 9/20 0.71
ALDH1A1 P00352 7/20 0.71
L3MBTL1 Q9Y468 6/20 0.71
LMNA P02545 3/20 0.64
GAA P10253 3/20 0.64
MEN1 O00255 1/20 0.64
KMT2A Q03164 1/20 0.64
NPSR1 Q6W5P4 1/20 0.63
MAPT P10636 2/20 0.62
RAB9A P51151 2/20 0.62
POLB P06746 1/20 0.62
AKT1 P31749 1/20 0.59
AKT2 P31751 1/20 0.59
ADORA2A P29274 1/20 0.58
PKM P14618 1/20 0.55
PDE10A Q9Y233 1/20 0.55
HPGD P15428 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6341547 0.96 TDP1 (0.91) TDP1KDM4EALDH1A1L3MBTL1LMNA
SCHEMBL14733982 0.93 TDP1 (0.88) TDP1KDM4EALDH1A1L3MBTL1LMNA
SCHEMBL26867246 0.89 TDP1 (0.79) TDP1KDM4EALDH1A1L3MBTL1MEN1
SCHEMBL16659834 0.89 TDP1 (0.79) TDP1KDM4EALDH1A1L3MBTL1MEN1
SCHEMBL13950894 0.89 KDM4E (0.78) TDP1KDM4EALDH1A1L3MBTL1LMNA
SCHEMBL18083001 0.88 ALDH1A1 (0.93) TDP1KDM4EALDH1A1L3MBTL1LMNA
SCHEMBL12595616 0.88 ALDH1A1 (0.79) TDP1KDM4EALDH1A1L3MBTL1LMNA
SCHEMBL12595573 0.88 ALDH1A1 (0.79) TDP1KDM4EALDH1A1L3MBTL1LMNA
SCHEMBL12146748 0.88 TDP1 (0.77) TDP1KDM4EALDH1A1L3MBTL1LMNA
SCHEMBL12146746 0.88 TDP1 (0.77) TDP1KDM4EALDH1A1L3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105693632-B A kind of preparation method of polysubstituted quinoxaline derivant 华侨大学 2018-04-17 CN disclosed
CN-105693632-A Preparation method of polysubstitution quinoxalin derivatives 华侨大学 2016-06-22 CN disclosed
US-20160151363-A1 Cadherin-11 Inhibitors and Methods of Use Thereof GEORGETOWN UNIVERSITY (US) 2016-06-02 US disclosed
US-20150064168-A1 Cadherin-11 Inhibitors and Methods of Use Thereof UNITED STATES GOVERNMENT 2015-03-05 US disclosed
EP-2065378-B1 Quinoxaline derivate, and light-emitting element, light-emitting device, and electronic device using quinoxaline derivative SEMICONDUCTOR ENERGY LAB (JP) 2015-01-28 EP disclosed
US-20120128693-A1 CADHERIN-11 INHIBITORS AND METHODS OF USE THEREOF GEORGETOWN UNIVERSITY (US) 2012-05-24 US disclosed
EP-1342769-B1 Organic EL Device TDK CORP (JP) 2010-01-27 EP disclosed
EP-1992672-A1 Organic electroluminescent device TDK Corporation (JP) 2008-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150064168-A1 Cadherin-11 Inhibitors and Methods of Use Thereof CDH1, ICAM1, S100A11 TDP1 3242/4885KDM4E 2097/4885ALDH1A1 2041/4885
US-20160151363-A1 Cadherin-11 Inhibitors and Methods of Use Thereof CDH1, ICAM1, S100A11 TDP1 3242/4885KDM4E 2097/4885ALDH1A1 2041/4885
US-20120128693-A1 CADHERIN-11 INHIBITORS AND METHODS OF USE THEREOF CDH1, ICAM1, S100A11 TDP1 3242/4885KDM4E 2097/4885ALDH1A1 2041/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.